Topics

Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal

17:00 EST 3 Dec 2019 | Xconomy

Veracyte, a company whose tests help physicians make treatment decisions, is adding technology from NanoString to the fold to expand its diagnostic capabilities. South San Francisco-based Veracyte (NASDAQ: VCYT) announced Tuesday that it has reached a deal for global rights to develop and commercialize diagnostics based on the nCounter FLEX  system . The nCounter is […]

Original Article: Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal

NEXT ARTICLE

More From BioPortfolio on "Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal"

Quick Search